Valuation Dr. Reddy's Laboratories Limited NYSE

Stocks

Market Closed - NYSE 16:00:02 2026-09-11 EDT			5-day change	1st Jan Change
11.90 ^USD	+1.62%		-1.08%	-15.24%

09-11	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	MT
09-10	Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	714,500	767,655	1,024,969	953,168	1,044,616	967,095	-	-
Change	-	7.44%	33.52%	-7.01%	9.59%	-7.42%	-	-
Enterprise Value (EV) ¹	703,980	719,330	960,383	928,633	1,011,902	935,513	915,477	885,040
Change	-	2.18%	33.51%	-3.31%	8.97%	-7.55%	-2.14%	-3.32%
P/E	30.4x	17.1x	18.4x	16.9x	24.4x	25.7x	20x	16.8x
PBR	3.76x	3.33x	3.63x	2.86x	2.78x	2.38x	2.15x	1.95x
PEG	-	0.2x	0.8x	13.12x	-1x	-2.1x	0.7x	0.9x
Capitalization / Revenue	3.33x	3.11x	3.67x	2.93x	3.11x	2.75x	2.46x	2.23x
EV / Revenue	3.28x	2.92x	3.44x	2.85x	3.01x	2.66x	2.33x	2.04x
EV / EBITDA	13.7x	11.1x	12.1x	10.8x	15.1x	15.1x	11.4x	9.65x
EV / EBIT	20.5x	13.8x	14.8x	13.4x	21.8x	22.5x	15.9x	13.2x
EV / FCF	52.3x	15.1x	33.1x	49.1x	30.3x	23.6x	25.2x	18.3x
FCF Yield	1.91%	6.61%	3.02%	2.04%	3.3%	4.24%	3.96%	5.45%
Dividend per Share ²	6	8	8	8	8	7.543	8.386	9.156
Rate of return	0.7%	0.87%	0.65%	0.7%	0.64%	0.65%	0.72%	0.79%
EPS ²	28.34	54.18	66.92	67.78	51.42	45.16	58.18	69.18
Distribution rate	21.2%	14.8%	12%	11.8%	15.6%	16.7%	14.4%	13.2%
Net sales ¹	214,391	246,697	279,164	325,535	335,933	351,836	392,693	432,813
EBITDA ¹	51,400	64,559	79,481	86,236	67,048	62,039	80,033	91,743
EBIT ¹	34,277	52,057	64,781	69,178	46,443	41,599	57,465	67,249
Net income ¹	23,568	45,073	55,779	56,544	42,850	37,212	48,978	57,716
Net Debt ¹	-10,520	-48,325	-64,586	-24,535	-32,714	-31,582	-51,618	-82,055
Reference price ²	861.08	924.30	1,231.03	1,144.05	1,254.65	1,161.00	1,161.00	1,161.00
Nbr of stocks (in thousands)	829,771	830,526	832,611	833,152	832,596	832,984	-	-
Announcement Date	5/19/22	5/10/23	5/7/24	5/9/25	5/12/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	31.96x	11.62x	23.56x	0.62%	1,001B
JOHNSON & JOHNSON	29.63x	-	-	2.02%	642B
ABBVIE INC.	32.65x	7.56x	15.72x	2.69%	451B
ROCHE HOLDING AG	18.78x	4.58x	11.35x	2.9%	340B
NOVARTIS AG	19.52x	5.11x	12.66x	3.19%	263B
ASTRAZENECA PLC	20.44x	4.2x	12.01x	2.1%	247B
AMGEN INC.	24.19x	6.38x	11.35x	2.64%	207B
NOVO NORDISK A/S	12.74x	4.63x	9.67x	3.94%	197B
GILEAD SCIENCES, INC.	-43.8x	6.4x	24.98x	2.27%	180B
Average	16.23x	6.31x	15.16x	2.48%	391.82B
Weighted average by Cap.	23.23x	7.75x	17.18x	2.04%